Robert O Wright, MD, MPH
img_Robert O Wright
PROFESSOR AND SYSTEM CHAIR | Environmental Medicine & Public Health
PROFESSOR | Pediatrics
Research Topics
Biostatistics, Epigenetics
Multi-Disciplinary Training Area
Neuroscience [NEU]
Dr. Robert Wright’s research focuses on environmental factors which influence child health and neurodevelopment. He is specifically interested in chemical mixtures and exposomic approaches to study neurodevelopment and reproductive health. His research combines state of the art research techniques in both environmental health, exposure science, and epigenetic epidemiology. As an interdisciplinary scientist, he bridges the communication gap between these fields and is leading the design and conduct of sophisticated epidemiologic research in children’s environmental health. He has been the PI of multiple NIH RO1’s (R01 ES013744, R01ES020268, R01ES021357, R01ES026033) supporting epidemiologic cohort studies in Mexico City. He is the director and founder of the Mount Sinai P30 Core Center in Transdisciplinary Environmental Health Research and the Mount Sinai CHEAR (Child Health Exposure Analysis Resource) Lab Hub. Before joining Mount Sinai he directed an NIH funded Superfund Program Project grant (P42 ES016454). He founded and leads the Senator Frank Lautenberg Laboratory in Environmental Health Sciences and the newly established Mount Sinai Institute for Exposomic Research.

BS, University of Michigan-Dearborn

MD, University of Michigan

MPH, Harvard School of Public Health

Young Investigator Award, Society for Academic Emergency Medicine

Charlotte Promersberger Johnston Endowed Lectureship, Medical College of Wisconsin-Milwaukee

Mount Sinai Establishes Institute for Exposomic Research
Mount Sinai Spotlight: Climate Change Effects On Health
NY1 Talks with Drs  Robert Wright and Manish Arora about their latest research
Exposomics: The Last Frontier in Biological Science
Uncovering the Potential of the Exposome to Understand Health with Robert Wright, MD, MPH
Introductory Remarks with Robert Wright, MD, MPH
View All Videos

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Dr. Wright did not report having any of the following types of financial relationships with industry during 2022 and/or 2023: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.